GlassScriptPhysician profile
Trent Phan
NPI 1992725980
$6,301.48
in general payments reported to CMS, 2019-2025
8 companies · $378 in 2025
The $378 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $124 · 2021: $339 · 2022: $1,688 · 2023: $2,150 · 2024: $1,623 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,288 · Food and Beverage: $1,863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,288.04 |
| Food and Beverage | $1,862.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,404.54 | 2021-2025 | Indigo System, Penumbra System |
| Inari Medical, INC. | $2,229.32 | 2020-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $263.52 | 2025 | Flowtriever, Clottriever Bold Catheter, Flowtriever Catheter, S |
| Nevro Corp. | $216.45 | 2024 | Senza |
| Medtronic, INC. | $111.32 | 2021-2023 | Concertotm |
| Argon Medical Devices, INC. | $30.45 | 2020-2021 | |
| Abiomed | $25.64 | 2021 | |
| Cook Medical LLC | $20.24 | 2024 | Cook |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trent Phan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.